T Cell Production Patent Application
Summary
The European Patent Office published patent application EP4053267A1 for a method of producing T cells, filed by Kyoto University and Takeda Pharmaceutical Company Limited. The A1 publication indicates the application has passed formal examination and is now publicly available for opposition purposes. This is a standard patent publication notice with no regulatory compliance implications.
What changed
The EPO published patent application EP4053267A1 titled 'METHOD FOR PRODUCING T CELL' on March 25, 2026. The application covers methods for producing T cells with inventors Kaneko Shin, Yano Hisashi, and Shinohara Tokuyuki. Designated states include all current EU member states and extension countries. IPC classifications indicate cell therapy technology in the C12N field.
Patent publications do not create compliance obligations for regulated entities. No action is required by compliance teams. Interested parties who wish to oppose the patent may file observations during the opposition period following grant.
Source document (simplified)
METHOD FOR PRODUCING T CELL
Publication EP4053267A1 Kind: A1 Mar 25, 2026
Applicants
Kyoto University, Takeda Pharmaceutical Company Limited
Inventors
KANEKO Shin, YANO Hisashi, SHINOHARA Tokuyuki
IPC Classifications
C12N 5/0783 20100101AFI20240214BHEP C12N 5/10 20060101ALI20240214BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.